• Psoriasis is characterized by extensive new blood vessel formation.
What's already known about this topic?
• Psoriasis is characterized by extensive new blood vessel formation.
• Early microvascular modifications in the psoriatic lesion have received limited attention in psoriasis pathogenesis.
What does this study add?
• Psoriasin expression is promoted by ROS and hypoxia in keratinocytes. It regulates the ROS-induced expression of several psoriasis-associated angiogenic factors, and acts on dermal endothelial cells to promote key features of the angiogenic process.
INTRODUCTION
Psoriasis is a chronic inflammatory skin disease characterized by an intense hyperproliferation and a disturbed maturation of keratinocytes, an inflammatory dermal infiltrate and the formation of new blood vessels, in particular alterations of postcapillary venules within the rete ridges [1] [2] [3] [4] . Microvascular modifications constitute one of the earliest detectable changes in the development of the psoriatic lesion 5, 6 . These modifications include dilatation, hyperpermeability, tortuosity and elongation of dermal blood vessels and proliferation of endothelial cells 7 . The vascular alterations in psoriasis promote skin inflammation through the recruitment of leukocytes to lesional skin 8 . Several pro-angiogenic factors are upregulated in the psoriatic epidermis. Vascular endothelial growth factor (VEGF), a major epidermis-derived growth factor, is strongly upregulated in psoriatic skin 9 and is important in the initiation of the psoriatic phenotype 10 . Interestingly, the increased expression of VEGF is also present in nonlesional skin 11 . Transgenic mice overexpressing VEGF develop an inflammatory skin disorder resembling psoriasis, with an increased density of tortuous capillaries 12 . Many of the treatments used clinically, including tumor necrosis factor (TNF)-α inhibitors, methotrexate and phototherapy, have anti-angiogenic properties 8 . Despite this, the vascular contribution to the pathogenesis of psoriasis has generally received limited attention. In fact, angiogenesis in psoriasis was recently identified as a "research gap" in the field of psoriasis 13 .
Psoriasin (S100A7) was originally identified as being highly expressed in psoriatic lesions 14 .
It belongs to the S100 family of calcium binding proteins that are involved in several cellular processes including proliferation, differentiation, invasion and metastasis 15, 16 . An elevated expression of psoriasin has been detected in some carcinomas of epithelial origin, such as squamous cell carcinoma of the skin and bladder 17, 18 , as well as in breast cancer, where its expression has been linked to features of poor prognosis 19, 20 .
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In the skin, the expression of psoriasin is especially pronounced in psoriasis, but it is also elevated in other hyperproliferative and inflammatory disorders 21 . Psoriasin has a distinct antimicrobial effect on E. coli 14, 22, 23 and has been shown to be chemotactic for CD4+ T cells and neutrophils 24 . Psoriasin is induced by several pro-inflammatory cytokines present in psoriatic skin, such as interleukin (IL)-1, TNF-α, IL-17 and IL-22 25 .
The high expression of psoriasin in the psoriatic plaque, along with its elevated expression in other conditions characterized by angiogenesis, makes it a relevant protein to study in the context of angiogenesis.
In this study, we aimed to identify the role of psoriasin in the angiogenesis associated with psoriasis.
MATERIAL AND METHODS

Cell culture conditions and treatments
Neonatal human epidermal keratinocytes (HEKn) were cultured in Epilife medium (Cascade Biologics, Paisley, UK) as described 26 . Human embryonic kidney cells (293FT, Invitrogen, Carlsbad, CA) were grown in Dulbecco's modified Eagle's medium (DMEM, Gibco, Carlsbad, CA) supplemented with 10% fetal bovine serum (Gibco). The immortalized, non-transformed keratinocyte cell line N-TERT-2G was grown in keratinocyte serum-free medium medium (KFSM, Gibco) as described 27 . Human dermal-derived microvascular endothelial cells 
Induction of cellular stress
To study the effect of stress conditions on psoriasin production, HEKn were seeded at a density of 500,000 cells/T25 culture flask in complete Epilife medium. Following adherence, the medium was replaced with fresh medium containing 150 or 250 μM H2O2 (Sigma-Aldrich) for 24-48 hours (n=4), or 500 µM CoCl2 (Sigma-Aldrich) for 24 hours (n=4). To induce hypoxia (n=6), the adhered cells were given fresh medium and were subsequently moved to a hypoxic chamber with 1% O2 where they remained for 24 hours. Following treatment, cells were harvested and lysed in RLT-buffer (Qiagen, Hilden, Germany) for RNA extraction. Protein quantification was performed for n=9 in H2O2-treated cells and n=7 for hypoxia-treated cells.
Small interfering RNA (siRNA)
Psoriasin siRNA (Pso-siRNA) and a non-targeting siRNA (C-siRNA) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). HEKn were transfected with siRNA transfection reagent and siRNA in Opti-MEM (Gibco). Cells were stimulated with H2O2 24 hours after transfection. The downregulation of psoriasin was confirmed by quantitative real-time (q)PCR.
A total of 6 independent experiments were performed.
RNA extraction, cDNA synthesis and qPCR
RNA was prepared using the RNeasy mini kit (Qiagen) and cDNA was synthesized using the Maxima First Strand cDNA Synthesis Kit (Fermentas, Vilnius, Lithuania). mRNA expression was analyzed with qPCR on a real-time 7500HT sequence detection system with SYBR green detection (Applied Biosystems, Foster City, CA). The primers were previously described [28] [29] [30] [31] [32] or were designed using the Primer Express Software v3.0 (Applied Biosystems). All primer sequences are listed in supplemental table S1. GAPDH or RPLP0 were used as housekeeping genes. The relative expression of the target genes to untreated controls was determined using the comparative Ct method.
Cell proliferation and viability
HMVEC-d cells were seeded at 7,500 cells/well in a 96 well plate and were allowed to adhere before treatment. After adherence, the cell culture medium was replaced with basal medium containing either psoriasin (0.15 µg/mL or 1 µg/mL) or VEGF (10 ng/mL). Cells were allowed to proliferate for 24 hours and the proliferation and viability were determined using a CellTiter 
Tube formation assay
The formation of HMVEC-d in capillary-like structures was studied on Geltrex-reduced growth factor basement membrane matrix (Invitrogen), according to the manufacturer's instructions.
Briefly, a total of 60,000 HMVEC-d cells were seeded onto the matrix and were allowed to adhere. After adherence, cells were treated with psoriasin (0.15 µg/mL or 1 µg/mL; Abnova, Taipei, Taiwan) or VEGF (10 ng/mL). Tube formation was visualized after 18 hours of treatment using an Olympus IX51 inverted microscope and an Olympus DP70 camera (Olympus, Tokyo, Japan). Three independent experiments were performed. Tube formation assays were quantified in ImageJ with the macro Angiongenesis Analyzer (Gilles Carpentier.
ImageJ contribution: Angiogenesis Analyzer. ImageJ News, 5 October 2012) for ImageJ, detecting the total length, defined by the sum of length of segments, isolated elements and branches. As these experiments consisted of merely three repeats, statistical comparison of the quantifications was not deemed meaningful.
Scratch migration assay
The ability of psoriasin to mediate the migration of HMVEC-d was evaluated in a scratch migration assay. Cells were seeded densely in complete medium in 96 well plates and were allowed to adhere. 
Directional cloning of the psoriasin sequence
Total RNA was extracted from homogenized human psoriatic skin biopsies and cDNA synthesis was performed. Psoriasin (NM_002963) was amplified by PCR with gene specific primers. The forward primer included a short sequence at the 5'-end (CACC) for directional cloning into the pENTR/D-TOPO vector (Invitrogen). After PCR amplification and gel purification, the psoriasin DNA was cloned into pENTR followed by transformation into One Shot TOP10 chemically competent E. coli (Invitrogen). Insert DNA from positive clones was verified by DNA sequencing with M13 forward (5'GTAAAACGACGGCCAG-3') and reverse (5'-CAGGAAACAGCTATGAC-3') primers.
Lentivirus-mediated gene expression
Complementary DNA encoding the psoriasin gene was cloned into the lentiviral expression vectors pLenti6.3/TO/V5-DEST and used to produce infectious lentivirus particles in 293FT cells according to the manufacturer's instructions (Invitrogen). Keratinocytes with constitutive psoriasin expression were generated by infection of N-TERTs with the lentivirus constructs followed by selection with 10 µg/ml blasticidin. N-TERTs were seeded at a density of 5,000 cells/cm 2 and grown to 40% confluence. The medium was then replaced with new medium that was harvested after 24, 48 and 72 hours and cells were lysed with RLT buffer (Qiagen).
Enzyme-linked immunosorbent assay (ELISA)
The secreted levels of psoriasin, VEGF, MMP9 and IL-8 were quantitated using a psoriasin/S100A7 (Circulex, Woburn, MA), VEGF Quantikine (R&D Systems), MMP9
Quantikine (R&D Systems) or IL-8 Quantikine (R&D Systems) ELISA kit, according to the manufacturer's instructions. ELISAs were performed on cell culture supernatant or total protein extract. To obtain total protein cells were lysed in RIPA buffer (Thermo scientific, Rockford, IL) and the protein level was measured with a Bio-Rad protein assay (Hercules, CA).
The protein was diluted in assay buffer before the ELISA assay to avoid RIPA interference.
The absorbance of the assays was measured on a VersaMax Microplate Reader (Molecular Devices) at the recommended wavelengths.
Gene expression microarray
100 ng RNA extracted from three psoriasin-expressing or control N-TERTs (n=3) after 24
hours of culture was used to generate hybridization probes using the GeneChip® WT PLUS Reagent kit according to the manufacturer's instructions. Hybridization to GeneChip® human transcriptome arrays 2.0 was performed in a GeneChip® hybridization oven, followed by washing and staining in a GeneChip® Fluidics Station 450 and scanning in a GeneChip® Scanner 3000 7G system. Expression Console software (v1.2.1) was used to verify the quality controls. All GeneChip® products were from Affymetrix (Santa Clara, CA). Cel-files generated by the Affymetrix AGCC program were analyzed using Genespring GX software 
Statistical analysis
Statistical analysis was performed in GraphPad Prism 6 (GraphPad Software, La Jolla, CA) using a paired or unpaired Student's t-test and Wilcoxon's signed rank test. A value of p≤0.05
was considered statistically significant. The results are presented as the mean ± the standard deviation (SD).
RESULTS
Psoriasin expression is induced by cellular stress in keratinocytes
Pro-angiogenic factors are triggered by stress signals, such as oxidative stress and hypoxia. In psoriasis, the increased production of ROS overrides the effect of endogenous antioxidants 33 .
Treatment with H2O2 induced the expression of psoriasin in keratinocytes (Figure 1a and 1b) , with the highest induction seen upon treatment with 250 μM H2O2 after 48 hours. As expected, H2O2 also led to the expression of VEGF (Figure 2b and 1c) .
Hypoxia has been shown to induce the production of ROS 34 and a hypoxic state has been suggested in the psoriatic plaque 35 . We therefore cultured HEKn in a hypoxic chamber with 1% O2 for 24 hours. This culture significantly induced the expression of psoriasin ( Figure 1d and 1f), as well as the expression of VEGF, which functioned as a positive control (Figure 1e and 1g). Similarly, the hypoxia-mimicking agent, CoCl2, induced both psoriasin (Figure 1h) and VEGF expression (Figure 1i ). Our data demonstrate that the oxidative stress factors H2O2, hypoxia and CoCl2, all induce psoriasin expression in keratinocytes.
Psoriasin mediates H 2 O 2 -induced expression of psoriasis-associated angiogenic factors in keratinocytes
To determine whether psoriasis-associated factors of angiogenesis are affected by the expression of psoriasin, the levels of these factors were measured after treating keratinocytes 
Psoriasin does not influence angiogenic markers by upregulating VEGF receptors
We speculated that psoriasin might influence these angiogenic factors through the induction of the VEGF receptors R1 and -2, since many of these markers are VEGF targets. Treatment with extracellular psoriasin did not induce the mRNA expression of VEGFR1 and -2 in keratinocytes, nor did the treatment synergize with VEGF to upregulate these receptors (data not shown).
Overexpression of psoriasin leads to secretion of psoriasin into the extracellular space and altered expression of general regulators of angiogenesis
To further determine the effect of psoriasin on angiogenesis and the potential of the protein to influence surrounding cells, we generated keratinocytes with constitutively overexpressed psoriasin. The efficient upregulation of psoriasin expression was confirmed with qPCR (data not shown) and with a psoriasin ELISA which revealed a pronounced psoriasin expression at all the investigated time points (Figure 2h ). These results demonstrate not only the successful overexpression of psoriasin in the generated cells but also that psoriasin protein is highly In order to study the effect of secreted psoriasin on these steps, HMVEC-d were treated with psoriasin and investigated using an MTS and a Presto Blue viability assay to determine proliferation, a scratch assay to study migration and a tube network formation assay to evaluate angiogenic capacity.
Extracellular psoriasin induced the proliferation of the endothelial cells, as determined by the MTS assay (Figure 3a ) and the Presto Blue viability assay (Figure 3b ). This effect was found to be independent of VEGF as VEGF-neutralizing antibody did not abolish the proliferation Figure 3c ). Psoriasin also caused a pronounced cellular migration of HMVEC-d (Figure 3d ), comparable with that induced by the positive control VEGF. Furthermore, psoriasin triggered the formation of tube networks and generated more cell connections on Geltrex matrix than the basal medium control (Figure 3e ). In conclusion, our results demonstrate that extracellular psoriasin increases the angiogenic properties of dermal endothelial cells, to an extent comparable to that of extracellular VEGF.
Psoriasin-induced dermal-derived endothelial cell migration is mediated through the PI3K and NFκB pathways
VEGF and IL-17 activate the PI3K and NFκB signaling pathways in endothelial cells and regulate downstream target molecules involved in blood vessel growth and homeostasis 36, 37 .
To investigate whether these signaling pathways also underlie psoriasin-induced HMVEC-d migration, we examined the effect of inhibitors of PI3K (LY294002) or NFκB (CAPE) following treatment with psoriasin or IL-17. IL-17 was shown to stimulate HMVEC-d migration and was also used as the positive control (Figure 3f ). The promoting effect of psoriasin on HMVEC-d migration was effectively blocked by the inhibition of the PI3K ( Figure   3g ) and NFκB (Figure 3h ) pathways. LY294002 and CAPE alone had no effect on HMVEC-d migration; nor did DMSO, used as a diluent control.
Psoriasin induces the expression of angiogenic factors in dermal endothelial cells
To acquire further insights into the mechanisms by which psoriasin increases angiogenesis, we 
DISCUSSION
ROS play an important role in signal transduction and induce the transcription of cytokines, chemokines and growth factors which participate in many biological processes, including angiogenesis 38 . We have previously shown that psoriasin is induced by H2O2 in mammary epithelial cells and induces human umbilical vein endothelial cell proliferation 32, 39 . We have also demonstrated that the downregulation of psoriasin in a breast cancer cell line with a high endogenous expression of psoriasin led to decreased tumor growth in vivo 28 . In line with these findings, we also found the upregulation of MMP-13 and the downregulation of VEGF in cells with reduced psoriasin levels. Moreover, we observed a significant positive correlation between psoriasin expression and blood vessel density, determined by the immunohistochemical analysis of psoriasin and CD31, an endothelial cell-specific marker 28 .
In this study, we detected the upregulation of psoriasin by cellular stress in keratinocytes, such as the ROS H2O2 and hypoxia. Furthermore, we demonstrate that psoriasin regulates the expression of the psoriasis-associated angiogenic factors VEGF, HB-EGF, IL-8, MMP-1 and MMP-9 in H2O2-treated keratinocytes, as indicated by the diminished response to ROS when psoriasin is silenced with siRNA. We have previously shown that psoriasin in itself increases the intracellular levels of ROS in keratinocytes, suggesting a feedback loop where psoriasin is both induced by ROS and amplifies the angiogenic response to ROS 29 .
Among the factors that were regulated by psoriasin, VEGF is of particular interest because of its overexpression in psoriatic keratinocytes and its potent mitogenic effect on endothelial cells 6, 40 . Extracellular psoriasin also induced the expression of VEGF and IL-8 in dermal endothelial cells, in parallel with an induced cell proliferation. Furthermore, extracellular psoriasin also caused an increase in the expression of the RAGE receptor. As psoriasin is known to be a ligand of RAGE 41 , this suggests that the upregulation of this receptor upon psoriasin treatment may potentiate the response to psoriasin in an autocrine fashion.
The regulation of MMPs by psoriasin is also of interest, since they are involved in the proteolysis of the basement membrane that is a critical step during the very early stages of angiogenesis 42 . Similarly, HB-EGF, which is upregulated in the psoriatic lesion 43 , is a critical molecular component in wound healing and angiogenesis 44 . The increase in the anti-angiogenic factor THBS-1 expression in H2O2-treated keratinocytes with silenced psoriasin expression is in line with previous findings where we have observed a negative correlation between psoriasin and THBS-1 in normal and ductal carcinoma in situ (DCIS) specimens 45 . The microarray analysis of keratinocytes overexpressing psoriasin also suggests that psoriasin affects a broad range of angiogenic factors. We found that psoriasin is highly secreted and leads to the proliferation, migration and differentiation of dermal endothelial cells.
In conclusion, our findings demonstrate that psoriasin amplifies the stress-induced angiogenic response in keratinocytes and endothelial cells and is involved in potent pro-angiogenic activity in several crucial steps in the angiogenic process in vitro. These findings provide a link between psoriasin and angiogenesis and suggest that the high expression of psoriasin contributes to the increased vascularization in psoriatic epidermis and the progression of the disease. Our findings raise the possibility that psoriasin could be evaluated as a novel anti-angiogenic target in psoriasis. 
